BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 16963733)

  • 1. Is there a role for SV40 in human cancer?
    Poulin DL; DeCaprio JA
    J Clin Oncol; 2006 Sep; 24(26):4356-65. PubMed ID: 16963733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polio vaccines, Simian Virus 40, and human cancer: the epidemiologic evidence for a causal association.
    Dang-Tan T; Mahmud SM; Puntoni R; Franco EL
    Oncogene; 2004 Aug; 23(38):6535-40. PubMed ID: 15322523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poliovirus vaccination during pregnancy, maternal seroconversion to simian virus 40, and risk of childhood cancer.
    Engels EA; Chen J; Viscidi RP; Shah KV; Daniel RW; Chatterjee N; Klebanoff MA
    Am J Epidemiol; 2004 Aug; 160(4):306-16. PubMed ID: 15286015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simian virus 40, poliovirus vaccines, and human cancer: research progress versus media and public interests.
    Butel JS
    Bull World Health Organ; 2000; 78(2):195-8. PubMed ID: 10743284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Some oral poliovirus vaccines were contaminated with infectious SV40 after 1961.
    Cutrone R; Lednicky J; Dunn G; Rizzo P; Bocchetta M; Chumakov K; Minor P; Carbone M
    Cancer Res; 2005 Nov; 65(22):10273-9. PubMed ID: 16288015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SV40 association with human malignancies and mechanisms of tumor immunity by large tumor antigen.
    Lowe DB; Shearer MH; Jumper CA; Kennedy RC
    Cell Mol Life Sci; 2007 Apr; 64(7-8):803-14. PubMed ID: 17260087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simian virus 40 (SV40)-like DNA sequences not detectable in finnish mesothelioma patients not exposed to SV40-contaminated polio vaccines.
    Hirvonen A; Mattson K; Karjalainen A; Ollikainen T; Tammilehto L; Hovi T; Vainio H; Pass HI; Di Resta I; Carbone M; Linnainmaa K
    Mol Carcinog; 1999 Oct; 26(2):93-9. PubMed ID: 10506753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential exposure to SV40 in polio vaccines used in Sweden during 1957: no impact on cancer incidence rates 1960 to 1993.
    Olin P; Giesecke J
    Dev Biol Stand; 1998; 94():227-33. PubMed ID: 9776244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of SV40 with human tumours.
    Jasani B; Cristaudo A; Emri SA; Gazdar AF; Gibbs A; Krynska B; Miller C; Mutti L; Radu C; Tognon M; Procopio A
    Semin Cancer Biol; 2001 Feb; 11(1):49-61. PubMed ID: 11243899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does simian virus 40 cause non-Hodgkin lymphoma? A review of the laboratory and epidemiological evidence.
    Engels EA
    Cancer Invest; 2005; 23(6):529-36. PubMed ID: 16203661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case-control study of simian virus 40 and non-Hodgkin lymphoma in the United States.
    Engels EA; Viscidi RP; Galloway DA; Carter JJ; Cerhan JR; Davis S; Cozen W; Severson RK; de Sanjose S; Colt JS; Hartge P
    J Natl Cancer Inst; 2004 Sep; 96(18):1368-74. PubMed ID: 15367569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of SV40 infection in patients with nodal non-Hodgkin's lymphoma but not acute leukemia independent of contaminated polio vaccines in Taiwan.
    Chen PM; Yen CC; Yang MH; Poh SB; Hsiao LT; Wang WS; Lin PC; Lee MY; Teng HW; Bai LY; Chu CJ; Chao SC; Yang AH; Chiou TJ; Liu JH; Chao TC
    Cancer Invest; 2006; 24(3):223-8. PubMed ID: 16809147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral polio vaccine and human cancer: a reassessment of SV40 as a contaminant based upon legal documents.
    Kops SP
    Anticancer Res; 2000; 20(6C):4745-9. PubMed ID: 11205211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Live oral poliovirus vaccines do not contain detectable simian virus 40 (SV40) DNA.
    Sierra-Honigmann A; Krause PR
    Biologicals; 2000 Mar; 28(1):1-4. PubMed ID: 10799049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer risk associated with simian virus 40 contaminated polio vaccine.
    Fisher SG; Weber L; Carbone M
    Anticancer Res; 1999; 19(3B):2173-80. PubMed ID: 10472327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of serologic evidence for prevalent simian virus 40 infection in humans.
    Carter JJ; Madeleine MM; Wipf GC; Garcea RL; Pipkin PA; Minor PD; Galloway DA
    J Natl Cancer Inst; 2003 Oct; 95(20):1522-30. PubMed ID: 14559874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer risk associated with receipt of vaccines contaminated with simian virus 40: epidemiologic research.
    Engels EA
    Expert Rev Vaccines; 2005 Apr; 4(2):197-206. PubMed ID: 15889993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exposure to SV40-contaminated poliovirus vaccine and the risk of cancer--a review of the epidemiological evidence.
    Strickler HD; Goedert JJ
    Dev Biol Stand; 1998; 94():235-44. PubMed ID: 9776245
    [No Abstract]   [Full Text] [Related]  

  • 19. Contamination of poliovirus vaccines with simian virus 40 (1955-1963) and subsequent cancer rates.
    Strickler HD; Rosenberg PS; Devesa SS; Hertel J; Fraumeni JF; Goedert JJ
    JAMA; 1998 Jan; 279(4):292-5. PubMed ID: 9450713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyomavirus SV40 infections in Kazakhstan.
    Nurgalieva ZZ; Wong C; Zhangabylov AK; Omarbekova ZE; Graham DY; Vilchez RA; Butel JS
    J Infect; 2005 Feb; 50(2):142-8. PubMed ID: 15667916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.